Óskar Fannar Vilmundarson has been appointed Investment Director, Einar Þór Gústafsson has been appointed Investment Director, and Pétur Snær Auðunsson has joined as Analyst.
Brunnur III invests in startups and growth companies, with the goal of supporting strong teams building international companies out of Iceland.
Former Moderna executive Örn Almarsson, PhD, hopes to expand RNA therapeutic targets for autoimmune disease using proprietary lipid chemistry and AI
AviLabs has secured €8M in Series A funding to tackle airline passenger disruptions.
DTE has successfully managed to close a $16M Series A round in 2023
The history of Icelandic VC funds and the Icelandic start-up ecosystem.
Exceptional growth for start-up company hopp
Oculis became dual-listed on the Nasdaq Iceland Main Market, complementing its existing listing on the Nasdaq Global Market in the U.S. (Nasdaq: OCS).
